Johnson & Johnson's (JNJ) Management on Q3 2019 Results - Earnings Call Transcript

10/16/19

Johnson & Johnson (NYSE:JNJ) Q3 2019 Results Earnings Conference Call October 15, 2019 8:30 AM ET

Company Participants

Christopher DelOrefice - Vice President of Investor Relations

Joseph Wolk - Executive Vice President, Chief Financial Officer

Ashley McEvoy - Executive Vice President, Worldwide Chairman, Medical Devices

Jennifer Taubert - Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon - Executive Vice President, Worldwide Chairman, Consumer

Conference Call Participants

David Lewis - Morgan Stanley

Chris Schott - JPMorgan

Lawrence Biegelsen - Wells Fargo

Danielle Antalffy - SVB Leerink

Terence Flynn - Goldman Sachs

Kristen Stewart - Barclays

Josh Jennings - Cowen & Company

Matt Miksic - Credit Suisse

Bob Hopkins - Bank of America

Jayson Bedford - Raymond James

Operator

Good morning. Welcome to Johnson & Johnson's Third Quarter 2019 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. [Operator Instructions]

I would now like to turn the conference call over to Johnson & Johnson. You may begin.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.